Article Text
Abstract
Objective This study aimed to investigate the prevalence and distribution of hypertension and its related factors in Jilin province, China.
Design A cross-sectional study in four cities and four rural counties in Jilin as part of a national Chinese study.
Participants and setting A total of 15 206 participants who were ≥15 years old and were selected using a stratified multistage random sampling method.
Main outcome measures The prevalence of hypertension.
Results The prevalence of hypertension in Jilin province was 24.7%. Moreover, the prevalence of hypertension increased with age in both sexes, and was higher in men than in women. The modifiable factors that were associated with hypertension were body mass index, smoking and alcohol drinking. The risk factors identified are similar to those in southern China, except smoking, which has no association with hypertension prevalence in the South.
Conclusions Age, sex, body mass index, smoking and alcohol drinking were risk factors of hypertension. Control of these related risk factors, especially smoking, may be helpful in the treatment and management of hypertension in Jilin province.
- prevalence
- hypertension
- epidemiology
- China
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Contributors BL was involved in the study’s design. JW, XS, LL, YY, YL and CQ collected the data. YZ and YL performed the statistical analysis. TL, WS and BL wrote the paper. All authors reviewed and approved the final version of the paper.
Funding This work was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BAI11B01) from the Chinese Ministry of Science and Technology and the National Clinical Key Specialty Project.
Competing interests None declared.
Patient consent Not required.
Ethics approval This study was approved by the Fuwai Hospital Ethics Review Board.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.